nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—ESR2—obesity	0.205	0.438	CbGaD
Raloxifene—CYP19A1—obesity	0.138	0.293	CbGaD
Raloxifene—ESR1—obesity	0.127	0.27	CbGaD
Raloxifene—CYP2B6—Benzphetamine—obesity	0.0587	0.224	CbGbCtD
Raloxifene—CYP2B6—Bupropion—obesity	0.0499	0.19	CbGbCtD
Raloxifene—CYP2C8—Bupropion—obesity	0.0378	0.144	CbGbCtD
Raloxifene—CYP2C8—Cimetidine—obesity	0.0277	0.106	CbGbCtD
Raloxifene—CYP3A4—Sibutramine—obesity	0.0238	0.0907	CbGbCtD
Raloxifene—CYP3A4—Benzphetamine—obesity	0.018	0.0687	CbGbCtD
Raloxifene—CYP3A4—Bupropion—obesity	0.0153	0.0584	CbGbCtD
Raloxifene—CYP3A4—Orlistat—obesity	0.0125	0.0476	CbGbCtD
Raloxifene—CYP3A4—Cimetidine—obesity	0.0112	0.0429	CbGbCtD
Raloxifene—CYP3A4—Topiramate—obesity	0.00736	0.0281	CbGbCtD
Raloxifene—ESR2—ovarian follicle—obesity	0.00729	0.147	CbGeAlD
Raloxifene—CYP19A1—ovarian follicle—obesity	0.00574	0.116	CbGeAlD
Raloxifene—ESR1—ovarian follicle—obesity	0.00499	0.101	CbGeAlD
Raloxifene—ESR2—hindbrain—obesity	0.00158	0.0318	CbGeAlD
Raloxifene—AOX1—gall bladder—obesity	0.0015	0.0302	CbGeAlD
Raloxifene—EBP—endocrine gland—obesity	0.00145	0.0293	CbGeAlD
Raloxifene—EBP—liver—obesity	0.00131	0.0264	CbGeAlD
Raloxifene—ESR1—hindbrain—obesity	0.00108	0.0218	CbGeAlD
Raloxifene—AOX1—islet of Langerhans—obesity	0.000981	0.0198	CbGeAlD
Raloxifene—ESR2—respiratory system—obesity	0.000962	0.0194	CbGeAlD
Raloxifene—SIGMAR1—islet of Langerhans—obesity	0.000789	0.0159	CbGeAlD
Raloxifene—AOX1—adrenal cortex—obesity	0.000777	0.0157	CbGeAlD
Raloxifene—ESR2—cardiovascular system—obesity	0.000737	0.0149	CbGeAlD
Raloxifene—ESR1—respiratory system—obesity	0.000659	0.0133	CbGeAlD
Raloxifene—ESR2—pituitary gland—obesity	0.000652	0.0132	CbGeAlD
Raloxifene—AOX1—pituitary gland—obesity	0.000628	0.0127	CbGeAlD
Raloxifene—SIGMAR1—adrenal cortex—obesity	0.000626	0.0126	CbGeAlD
Raloxifene—AOX1—adipose tissue—obesity	0.000625	0.0126	CbGeAlD
Raloxifene—HTR2B—adrenal cortex—obesity	0.000624	0.0126	CbGeAlD
Raloxifene—ESR2—digestive system—obesity	0.000612	0.0124	CbGeAlD
Raloxifene—AOX1—digestive system—obesity	0.000589	0.0119	CbGeAlD
Raloxifene—ESR2—adrenal gland—obesity	0.000583	0.0118	CbGeAlD
Raloxifene—HTR2B—cardiovascular system—obesity	0.00057	0.0115	CbGeAlD
Raloxifene—AOX1—adrenal gland—obesity	0.000561	0.0113	CbGeAlD
Raloxifene—CYP19A1—adipose tissue—obesity	0.000512	0.0103	CbGeAlD
Raloxifene—SIGMAR1—pituitary gland—obesity	0.000506	0.0102	CbGeAlD
Raloxifene—ESR2—endocrine gland—obesity	0.000505	0.0102	CbGeAlD
Raloxifene—ESR1—cardiovascular system—obesity	0.000505	0.0102	CbGeAlD
Raloxifene—SIGMAR1—adipose tissue—obesity	0.000503	0.0102	CbGeAlD
Raloxifene—HTR2B—adipose tissue—obesity	0.000502	0.0101	CbGeAlD
Raloxifene—CYP2B6—respiratory system—obesity	0.000487	0.00984	CbGeAlD
Raloxifene—AOX1—endocrine gland—obesity	0.000487	0.00983	CbGeAlD
Raloxifene—HTR2B—digestive system—obesity	0.000473	0.00955	CbGeAlD
Raloxifene—CYP19A1—adrenal gland—obesity	0.000459	0.00928	CbGeAlD
Raloxifene—ESR2—liver—obesity	0.000456	0.00921	CbGeAlD
Raloxifene—SIGMAR1—adrenal gland—obesity	0.000452	0.00912	CbGeAlD
Raloxifene—Chest pain—Diethylpropion—obesity	0.000451	0.00396	CcSEcCtD
Raloxifene—HTR2B—adrenal gland—obesity	0.000451	0.0091	CbGeAlD
Raloxifene—Insomnia—Phentermine—obesity	0.00045	0.00394	CcSEcCtD
Raloxifene—ESR1—pituitary gland—obesity	0.000447	0.00903	CbGeAlD
Raloxifene—ESR1—adipose tissue—obesity	0.000445	0.00899	CbGeAlD
Raloxifene—Dizziness—Benzphetamine—obesity	0.000441	0.00387	CcSEcCtD
Raloxifene—Migraine—Sibutramine—obesity	0.00044	0.00386	CcSEcCtD
Raloxifene—Gastroenteritis—Bupropion—obesity	0.00044	0.00386	CcSEcCtD
Raloxifene—AOX1—liver—obesity	0.000439	0.00886	CbGeAlD
Raloxifene—Dyspepsia—Phentermine—obesity	0.000438	0.00384	CcSEcCtD
Raloxifene—Headache—Methamphetamine—obesity	0.000434	0.0038	CcSEcCtD
Raloxifene—Arthralgia—Cimetidine—obesity	0.000429	0.00376	CcSEcCtD
Raloxifene—Myalgia—Cimetidine—obesity	0.000429	0.00376	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Phentermine—obesity	0.000429	0.00376	CcSEcCtD
Raloxifene—ESR1—digestive system—obesity	0.000419	0.00846	CbGeAlD
Raloxifene—Hyperhidrosis—Diethylpropion—obesity	0.000418	0.00367	CcSEcCtD
Raloxifene—Headache—Benzphetamine—obesity	0.000418	0.00367	CcSEcCtD
Raloxifene—Breast disorder—Orlistat—obesity	0.000418	0.00366	CcSEcCtD
Raloxifene—Hot flush—Bupropion—obesity	0.000417	0.00366	CcSEcCtD
Raloxifene—Diarrhoea—Phendimetrazine—obesity	0.000416	0.00365	CcSEcCtD
Raloxifene—Menopausal symptoms—Bupropion—obesity	0.000413	0.00362	CcSEcCtD
Raloxifene—CYP2B6—adrenal cortex—obesity	0.000409	0.00826	CbGeAlD
Raloxifene—Thrombocytopenia—Cimetidine—obesity	0.000403	0.00353	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Sibutramine—obesity	0.000403	0.00353	CcSEcCtD
Raloxifene—Dizziness—Phendimetrazine—obesity	0.000402	0.00353	CcSEcCtD
Raloxifene—Arthritis—Bupropion—obesity	0.000401	0.00352	CcSEcCtD
Raloxifene—Influenza—Orlistat—obesity	0.0004	0.0035	CcSEcCtD
Raloxifene—ESR1—adrenal gland—obesity	0.000399	0.00806	CbGeAlD
Raloxifene—CYP19A1—endocrine gland—obesity	0.000398	0.00805	CbGeAlD
Raloxifene—Cerebrovascular accident—Bupropion—obesity	0.000398	0.00349	CcSEcCtD
Raloxifene—Nausea—Benzphetamine—obesity	0.000396	0.00348	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Diethylpropion—obesity	0.000394	0.00346	CcSEcCtD
Raloxifene—Abdominal pain—Phentermine—obesity	0.000393	0.00345	CcSEcCtD
Raloxifene—Breast pain—Topiramate—obesity	0.000392	0.00344	CcSEcCtD
Raloxifene—Insomnia—Diethylpropion—obesity	0.000391	0.00343	CcSEcCtD
Raloxifene—Vasodilation—Topiramate—obesity	0.00039	0.00342	CcSEcCtD
Raloxifene—Vasodilation procedure—Topiramate—obesity	0.00039	0.00342	CcSEcCtD
Raloxifene—Influenza—Sibutramine—obesity	0.000387	0.00339	CcSEcCtD
Raloxifene—Migraine—Bupropion—obesity	0.000384	0.00337	CcSEcCtD
Raloxifene—Headache—Phendimetrazine—obesity	0.000381	0.00334	CcSEcCtD
Raloxifene—Dyspepsia—Diethylpropion—obesity	0.000381	0.00334	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Cimetidine—obesity	0.000375	0.00329	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Diethylpropion—obesity	0.000373	0.00327	CcSEcCtD
Raloxifene—CYP2B6—cardiovascular system—obesity	0.000373	0.00753	CbGeAlD
Raloxifene—Bronchitis—Sibutramine—obesity	0.000372	0.00326	CcSEcCtD
Raloxifene—CYP2C8—pituitary gland—obesity	0.000368	0.00744	CbGeAlD
Raloxifene—Nausea—Phendimetrazine—obesity	0.000361	0.00317	CcSEcCtD
Raloxifene—CYP19A1—liver—obesity	0.000359	0.00725	CbGeAlD
Raloxifene—Depression—Orlistat—obesity	0.000355	0.00311	CcSEcCtD
Raloxifene—SIGMAR1—liver—obesity	0.000353	0.00713	CbGeAlD
Raloxifene—Breast disorder—Bupropion—obesity	0.000353	0.00309	CcSEcCtD
Raloxifene—Weight increased—Sibutramine—obesity	0.000352	0.00309	CcSEcCtD
Raloxifene—Pneumonia—Sibutramine—obesity	0.000347	0.00304	CcSEcCtD
Raloxifene—Urinary tract infection—Orlistat—obesity	0.000346	0.00304	CcSEcCtD
Raloxifene—ESR1—endocrine gland—obesity	0.000346	0.00699	CbGeAlD
Raloxifene—Depression—Sibutramine—obesity	0.000344	0.00301	CcSEcCtD
Raloxifene—Dizziness—Phenylpropanolamine—obesity	0.000344	0.00301	CcSEcCtD
Raloxifene—Pulmonary embolism—Topiramate—obesity	0.000342	0.003	CcSEcCtD
Raloxifene—Vaginal inflammation—Topiramate—obesity	0.000342	0.003	CcSEcCtD
Raloxifene—Diarrhoea—Phentermine—obesity	0.00034	0.00298	CcSEcCtD
Raloxifene—Influenza—Bupropion—obesity	0.000337	0.00296	CcSEcCtD
Raloxifene—Conjunctivitis—Sibutramine—obesity	0.000335	0.00294	CcSEcCtD
Raloxifene—Urinary tract infection—Sibutramine—obesity	0.000335	0.00294	CcSEcCtD
Raloxifene—Cystitis noninfective—Topiramate—obesity	0.000334	0.00293	CcSEcCtD
Raloxifene—Sinusitis—Orlistat—obesity	0.000334	0.00293	CcSEcCtD
Raloxifene—Cystitis—Topiramate—obesity	0.000331	0.0029	CcSEcCtD
Raloxifene—Sweating—Sibutramine—obesity	0.000331	0.0029	CcSEcCtD
Raloxifene—Vomiting—Phenylpropanolamine—obesity	0.00033	0.0029	CcSEcCtD
Raloxifene—Dizziness—Phentermine—obesity	0.000329	0.00288	CcSEcCtD
Raloxifene—Rash—Phenylpropanolamine—obesity	0.000328	0.00287	CcSEcCtD
Raloxifene—Dermatitis—Phenylpropanolamine—obesity	0.000327	0.00287	CcSEcCtD
Raloxifene—Body temperature increased—Cimetidine—obesity	0.000325	0.00285	CcSEcCtD
Raloxifene—Bronchitis—Bupropion—obesity	0.000324	0.00284	CcSEcCtD
Raloxifene—Sinusitis—Sibutramine—obesity	0.000324	0.00284	CcSEcCtD
Raloxifene—Vaginal infection—Topiramate—obesity	0.000323	0.00283	CcSEcCtD
Raloxifene—Pharyngitis—Orlistat—obesity	0.000317	0.00278	CcSEcCtD
Raloxifene—Vomiting—Phentermine—obesity	0.000316	0.00277	CcSEcCtD
Raloxifene—Urinary tract disorder—Orlistat—obesity	0.000316	0.00277	CcSEcCtD
Raloxifene—Oedema peripheral—Orlistat—obesity	0.000315	0.00276	CcSEcCtD
Raloxifene—Cramps of lower extremities—Topiramate—obesity	0.000315	0.00276	CcSEcCtD
Raloxifene—Urethral disorder—Orlistat—obesity	0.000314	0.00275	CcSEcCtD
Raloxifene—Rash—Phentermine—obesity	0.000314	0.00275	CcSEcCtD
Raloxifene—Dermatitis—Phentermine—obesity	0.000313	0.00275	CcSEcCtD
Raloxifene—ESR1—liver—obesity	0.000312	0.00631	CbGeAlD
Raloxifene—Headache—Phentermine—obesity	0.000312	0.00273	CcSEcCtD
Raloxifene—Rhinitis—Sibutramine—obesity	0.00031	0.00272	CcSEcCtD
Raloxifene—CYP2B6—digestive system—obesity	0.00031	0.00625	CbGeAlD
Raloxifene—Bladder pain—Topiramate—obesity	0.00031	0.00271	CcSEcCtD
Raloxifene—Nausea—Phenylpropanolamine—obesity	0.000309	0.00271	CcSEcCtD
Raloxifene—Hypoaesthesia—Sibutramine—obesity	0.000308	0.0027	CcSEcCtD
Raloxifene—Pharyngitis—Sibutramine—obesity	0.000307	0.00269	CcSEcCtD
Raloxifene—Weight increased—Bupropion—obesity	0.000307	0.00269	CcSEcCtD
Raloxifene—Oedema peripheral—Sibutramine—obesity	0.000305	0.00267	CcSEcCtD
Raloxifene—Pneumonia—Bupropion—obesity	0.000302	0.00265	CcSEcCtD
Raloxifene—Diarrhoea—Diethylpropion—obesity	0.000296	0.00259	CcSEcCtD
Raloxifene—Nausea—Phentermine—obesity	0.000295	0.00259	CcSEcCtD
Raloxifene—CYP2B6—adrenal gland—obesity	0.000295	0.00596	CbGeAlD
Raloxifene—Urinary tract infection—Bupropion—obesity	0.000292	0.00256	CcSEcCtD
Raloxifene—Conjunctivitis—Bupropion—obesity	0.000292	0.00256	CcSEcCtD
Raloxifene—Sweating—Bupropion—obesity	0.000288	0.00253	CcSEcCtD
Raloxifene—Dizziness—Diethylpropion—obesity	0.000286	0.00251	CcSEcCtD
Raloxifene—Diabetes mellitus—Topiramate—obesity	0.000286	0.0025	CcSEcCtD
Raloxifene—CYP2C8—endocrine gland—obesity	0.000285	0.00576	CbGeAlD
Raloxifene—Sinusitis—Bupropion—obesity	0.000282	0.00247	CcSEcCtD
Raloxifene—Diarrhoea—Cimetidine—obesity	0.000282	0.00247	CcSEcCtD
Raloxifene—Angiopathy—Sibutramine—obesity	0.000281	0.00246	CcSEcCtD
Raloxifene—Gastroenteritis—Topiramate—obesity	0.00028	0.00246	CcSEcCtD
Raloxifene—Vomiting—Diethylpropion—obesity	0.000275	0.00241	CcSEcCtD
Raloxifene—Flatulence—Orlistat—obesity	0.000274	0.00241	CcSEcCtD
Raloxifene—Rash—Diethylpropion—obesity	0.000273	0.00239	CcSEcCtD
Raloxifene—Dermatitis—Diethylpropion—obesity	0.000273	0.00239	CcSEcCtD
Raloxifene—Dizziness—Cimetidine—obesity	0.000272	0.00239	CcSEcCtD
Raloxifene—Headache—Diethylpropion—obesity	0.000271	0.00238	CcSEcCtD
Raloxifene—Rhinitis—Bupropion—obesity	0.000271	0.00237	CcSEcCtD
Raloxifene—Hypoaesthesia—Bupropion—obesity	0.000269	0.00235	CcSEcCtD
Raloxifene—Pharyngitis—Bupropion—obesity	0.000268	0.00235	CcSEcCtD
Raloxifene—Muscle spasms—Orlistat—obesity	0.000268	0.00235	CcSEcCtD
Raloxifene—Urinary tract disorder—Bupropion—obesity	0.000267	0.00234	CcSEcCtD
Raloxifene—Oedema peripheral—Bupropion—obesity	0.000266	0.00233	CcSEcCtD
Raloxifene—Hot flush—Topiramate—obesity	0.000266	0.00233	CcSEcCtD
Raloxifene—Flatulence—Sibutramine—obesity	0.000266	0.00233	CcSEcCtD
Raloxifene—Connective tissue disorder—Bupropion—obesity	0.000265	0.00232	CcSEcCtD
Raloxifene—Urethral disorder—Bupropion—obesity	0.000265	0.00232	CcSEcCtD
Raloxifene—Menopausal symptoms—Topiramate—obesity	0.000263	0.00231	CcSEcCtD
Raloxifene—Vomiting—Cimetidine—obesity	0.000262	0.00229	CcSEcCtD
Raloxifene—Rash—Cimetidine—obesity	0.00026	0.00228	CcSEcCtD
Raloxifene—Dermatitis—Cimetidine—obesity	0.000259	0.00227	CcSEcCtD
Raloxifene—Muscle spasms—Sibutramine—obesity	0.000259	0.00227	CcSEcCtD
Raloxifene—Headache—Cimetidine—obesity	0.000258	0.00226	CcSEcCtD
Raloxifene—CYP2C8—liver—obesity	0.000257	0.00519	CbGeAlD
Raloxifene—Nausea—Diethylpropion—obesity	0.000257	0.00225	CcSEcCtD
Raloxifene—CYP2B6—endocrine gland—obesity	0.000256	0.00517	CbGeAlD
Raloxifene—Flushing—Bupropion—obesity	0.00025	0.0022	CcSEcCtD
Raloxifene—Cardiac disorder—Bupropion—obesity	0.00025	0.0022	CcSEcCtD
Raloxifene—Vertigo—Orlistat—obesity	0.00025	0.00219	CcSEcCtD
Raloxifene—Angiopathy—Bupropion—obesity	0.000245	0.00215	CcSEcCtD
Raloxifene—Migraine—Topiramate—obesity	0.000245	0.00214	CcSEcCtD
Raloxifene—Nausea—Cimetidine—obesity	0.000245	0.00214	CcSEcCtD
Raloxifene—Cough—Orlistat—obesity	0.000243	0.00213	CcSEcCtD
Raloxifene—Vertigo—Sibutramine—obesity	0.000242	0.00212	CcSEcCtD
Raloxifene—Syncope—Sibutramine—obesity	0.000242	0.00212	CcSEcCtD
Raloxifene—Myalgia—Orlistat—obesity	0.000237	0.00208	CcSEcCtD
Raloxifene—Chest pain—Orlistat—obesity	0.000237	0.00208	CcSEcCtD
Raloxifene—Loss of consciousness—Sibutramine—obesity	0.000237	0.00208	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000235	0.00206	CcSEcCtD
Raloxifene—Cough—Sibutramine—obesity	0.000235	0.00206	CcSEcCtD
Raloxifene—CYP3A4—digestive system—obesity	0.000234	0.00472	CbGeAlD
Raloxifene—Flatulence—Bupropion—obesity	0.000232	0.00203	CcSEcCtD
Raloxifene—CYP2B6—liver—obesity	0.000231	0.00466	CbGeAlD
Raloxifene—Chest pain—Sibutramine—obesity	0.000229	0.00201	CcSEcCtD
Raloxifene—Arthralgia—Sibutramine—obesity	0.000229	0.00201	CcSEcCtD
Raloxifene—Myalgia—Sibutramine—obesity	0.000229	0.00201	CcSEcCtD
Raloxifene—Muscle spasms—Bupropion—obesity	0.000226	0.00198	CcSEcCtD
Raloxifene—Infection—Orlistat—obesity	0.000226	0.00198	CcSEcCtD
Raloxifene—Breast disorder—Topiramate—obesity	0.000225	0.00197	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Topiramate—obesity	0.000224	0.00196	CcSEcCtD
Raloxifene—Nervous system disorder—Orlistat—obesity	0.000223	0.00195	CcSEcCtD
Raloxifene—Skin disorder—Orlistat—obesity	0.000221	0.00194	CcSEcCtD
Raloxifene—Hyperhidrosis—Orlistat—obesity	0.00022	0.00193	CcSEcCtD
Raloxifene—Infection—Sibutramine—obesity	0.000218	0.00192	CcSEcCtD
Raloxifene—Shock—Sibutramine—obesity	0.000216	0.0019	CcSEcCtD
Raloxifene—Thrombocytopenia—Sibutramine—obesity	0.000215	0.00189	CcSEcCtD
Raloxifene—Skin disorder—Sibutramine—obesity	0.000214	0.00187	CcSEcCtD
Raloxifene—Hyperhidrosis—Sibutramine—obesity	0.000213	0.00186	CcSEcCtD
Raloxifene—Vertigo—Bupropion—obesity	0.000211	0.00185	CcSEcCtD
Raloxifene—Syncope—Bupropion—obesity	0.000211	0.00185	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Orlistat—obesity	0.000207	0.00182	CcSEcCtD
Raloxifene—Bronchitis—Topiramate—obesity	0.000207	0.00181	CcSEcCtD
Raloxifene—Loss of consciousness—Bupropion—obesity	0.000206	0.00181	CcSEcCtD
Raloxifene—Insomnia—Orlistat—obesity	0.000206	0.0018	CcSEcCtD
Raloxifene—Cough—Bupropion—obesity	0.000205	0.0018	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Sibutramine—obesity	0.0002	0.00176	CcSEcCtD
Raloxifene—Dyspepsia—Orlistat—obesity	0.0002	0.00175	CcSEcCtD
Raloxifene—Arthralgia—Bupropion—obesity	0.0002	0.00175	CcSEcCtD
Raloxifene—Myalgia—Bupropion—obesity	0.0002	0.00175	CcSEcCtD
Raloxifene—Chest pain—Bupropion—obesity	0.0002	0.00175	CcSEcCtD
Raloxifene—Insomnia—Sibutramine—obesity	0.000199	0.00174	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000199	0.00174	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Orlistat—obesity	0.000196	0.00172	CcSEcCtD
Raloxifene—Weight increased—Topiramate—obesity	0.000195	0.00171	CcSEcCtD
Raloxifene—Pain—Orlistat—obesity	0.000194	0.0017	CcSEcCtD
Raloxifene—Dyspepsia—Sibutramine—obesity	0.000194	0.0017	CcSEcCtD
Raloxifene—CYP3A4—endocrine gland—obesity	0.000193	0.0039	CbGeAlD
Raloxifene—Pneumonia—Topiramate—obesity	0.000193	0.00169	CcSEcCtD
Raloxifene—Depression—Topiramate—obesity	0.000191	0.00167	CcSEcCtD
Raloxifene—Infection—Bupropion—obesity	0.00019	0.00167	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Sibutramine—obesity	0.00019	0.00166	CcSEcCtD
Raloxifene—Shock—Bupropion—obesity	0.000189	0.00165	CcSEcCtD
Raloxifene—Pain—Sibutramine—obesity	0.000188	0.00165	CcSEcCtD
Raloxifene—Nervous system disorder—Bupropion—obesity	0.000188	0.00165	CcSEcCtD
Raloxifene—Thrombocytopenia—Bupropion—obesity	0.000188	0.00165	CcSEcCtD
Raloxifene—Skin disorder—Bupropion—obesity	0.000186	0.00163	CcSEcCtD
Raloxifene—Conjunctivitis—Topiramate—obesity	0.000186	0.00163	CcSEcCtD
Raloxifene—Urinary tract infection—Topiramate—obesity	0.000186	0.00163	CcSEcCtD
Raloxifene—Gastrointestinal pain—Orlistat—obesity	0.000186	0.00163	CcSEcCtD
Raloxifene—Hyperhidrosis—Bupropion—obesity	0.000185	0.00162	CcSEcCtD
Raloxifene—Gastrointestinal pain—Sibutramine—obesity	0.00018	0.00158	CcSEcCtD
Raloxifene—Sinusitis—Topiramate—obesity	0.00018	0.00158	CcSEcCtD
Raloxifene—Abdominal pain—Orlistat—obesity	0.00018	0.00157	CcSEcCtD
Raloxifene—Body temperature increased—Orlistat—obesity	0.00018	0.00157	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Bupropion—obesity	0.000175	0.00153	CcSEcCtD
Raloxifene—CYP3A4—liver—obesity	0.000174	0.00352	CbGeAlD
Raloxifene—Body temperature increased—Sibutramine—obesity	0.000174	0.00152	CcSEcCtD
Raloxifene—Abdominal pain—Sibutramine—obesity	0.000174	0.00152	CcSEcCtD
Raloxifene—Insomnia—Bupropion—obesity	0.000173	0.00152	CcSEcCtD
Raloxifene—Rhinitis—Topiramate—obesity	0.000172	0.00151	CcSEcCtD
Raloxifene—Hypoaesthesia—Topiramate—obesity	0.000171	0.0015	CcSEcCtD
Raloxifene—Pharyngitis—Topiramate—obesity	0.000171	0.0015	CcSEcCtD
Raloxifene—Urinary tract disorder—Topiramate—obesity	0.00017	0.00149	CcSEcCtD
Raloxifene—Oedema peripheral—Topiramate—obesity	0.000169	0.00148	CcSEcCtD
Raloxifene—Connective tissue disorder—Topiramate—obesity	0.000169	0.00148	CcSEcCtD
Raloxifene—Dyspepsia—Bupropion—obesity	0.000169	0.00148	CcSEcCtD
Raloxifene—Urethral disorder—Topiramate—obesity	0.000169	0.00148	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Bupropion—obesity	0.000166	0.00145	CcSEcCtD
Raloxifene—Pain—Bupropion—obesity	0.000164	0.00144	CcSEcCtD
Raloxifene—Flushing—Topiramate—obesity	0.00016	0.0014	CcSEcCtD
Raloxifene—Cardiac disorder—Topiramate—obesity	0.00016	0.0014	CcSEcCtD
Raloxifene—Gastrointestinal pain—Bupropion—obesity	0.000157	0.00137	CcSEcCtD
Raloxifene—Angiopathy—Topiramate—obesity	0.000156	0.00137	CcSEcCtD
Raloxifene—Diarrhoea—Orlistat—obesity	0.000155	0.00136	CcSEcCtD
Raloxifene—Body temperature increased—Bupropion—obesity	0.000152	0.00133	CcSEcCtD
Raloxifene—Abdominal pain—Bupropion—obesity	0.000152	0.00133	CcSEcCtD
Raloxifene—Diarrhoea—Sibutramine—obesity	0.00015	0.00132	CcSEcCtD
Raloxifene—Dizziness—Orlistat—obesity	0.00015	0.00132	CcSEcCtD
Raloxifene—Flatulence—Topiramate—obesity	0.000147	0.00129	CcSEcCtD
Raloxifene—Dizziness—Sibutramine—obesity	0.000145	0.00127	CcSEcCtD
Raloxifene—Vomiting—Orlistat—obesity	0.000144	0.00127	CcSEcCtD
Raloxifene—Muscle spasms—Topiramate—obesity	0.000144	0.00126	CcSEcCtD
Raloxifene—Rash—Orlistat—obesity	0.000143	0.00126	CcSEcCtD
Raloxifene—Dermatitis—Orlistat—obesity	0.000143	0.00125	CcSEcCtD
Raloxifene—Headache—Orlistat—obesity	0.000142	0.00125	CcSEcCtD
Raloxifene—Vomiting—Sibutramine—obesity	0.00014	0.00123	CcSEcCtD
Raloxifene—Rash—Sibutramine—obesity	0.000139	0.00122	CcSEcCtD
Raloxifene—Dermatitis—Sibutramine—obesity	0.000139	0.00121	CcSEcCtD
Raloxifene—Headache—Sibutramine—obesity	0.000138	0.00121	CcSEcCtD
Raloxifene—Nausea—Orlistat—obesity	0.000135	0.00118	CcSEcCtD
Raloxifene—Vertigo—Topiramate—obesity	0.000134	0.00118	CcSEcCtD
Raloxifene—Syncope—Topiramate—obesity	0.000134	0.00118	CcSEcCtD
Raloxifene—Loss of consciousness—Topiramate—obesity	0.000132	0.00115	CcSEcCtD
Raloxifene—Diarrhoea—Bupropion—obesity	0.000131	0.00115	CcSEcCtD
Raloxifene—Nausea—Sibutramine—obesity	0.000131	0.00115	CcSEcCtD
Raloxifene—Cough—Topiramate—obesity	0.000131	0.00114	CcSEcCtD
Raloxifene—Arthralgia—Topiramate—obesity	0.000127	0.00112	CcSEcCtD
Raloxifene—Chest pain—Topiramate—obesity	0.000127	0.00112	CcSEcCtD
Raloxifene—Myalgia—Topiramate—obesity	0.000127	0.00112	CcSEcCtD
Raloxifene—Dizziness—Bupropion—obesity	0.000127	0.00111	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000127	0.00111	CcSEcCtD
Raloxifene—Vomiting—Bupropion—obesity	0.000122	0.00107	CcSEcCtD
Raloxifene—Infection—Topiramate—obesity	0.000121	0.00106	CcSEcCtD
Raloxifene—Rash—Bupropion—obesity	0.000121	0.00106	CcSEcCtD
Raloxifene—Dermatitis—Bupropion—obesity	0.000121	0.00106	CcSEcCtD
Raloxifene—Shock—Topiramate—obesity	0.00012	0.00105	CcSEcCtD
Raloxifene—Headache—Bupropion—obesity	0.00012	0.00105	CcSEcCtD
Raloxifene—Nervous system disorder—Topiramate—obesity	0.00012	0.00105	CcSEcCtD
Raloxifene—Thrombocytopenia—Topiramate—obesity	0.00012	0.00105	CcSEcCtD
Raloxifene—Skin disorder—Topiramate—obesity	0.000119	0.00104	CcSEcCtD
Raloxifene—Hyperhidrosis—Topiramate—obesity	0.000118	0.00104	CcSEcCtD
Raloxifene—Nausea—Bupropion—obesity	0.000114	0.000998	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Topiramate—obesity	0.000111	0.000976	CcSEcCtD
Raloxifene—Insomnia—Topiramate—obesity	0.00011	0.000969	CcSEcCtD
Raloxifene—Dyspepsia—Topiramate—obesity	0.000108	0.000943	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Topiramate—obesity	0.000105	0.000925	CcSEcCtD
Raloxifene—Pain—Topiramate—obesity	0.000104	0.000916	CcSEcCtD
Raloxifene—Gastrointestinal pain—Topiramate—obesity	9.99e-05	0.000876	CcSEcCtD
Raloxifene—Abdominal pain—Topiramate—obesity	9.66e-05	0.000847	CcSEcCtD
Raloxifene—Body temperature increased—Topiramate—obesity	9.66e-05	0.000847	CcSEcCtD
Raloxifene—Diarrhoea—Topiramate—obesity	8.36e-05	0.000733	CcSEcCtD
Raloxifene—Dizziness—Topiramate—obesity	8.08e-05	0.000708	CcSEcCtD
Raloxifene—Vomiting—Topiramate—obesity	7.77e-05	0.000681	CcSEcCtD
Raloxifene—Rash—Topiramate—obesity	7.7e-05	0.000675	CcSEcCtD
Raloxifene—Dermatitis—Topiramate—obesity	7.7e-05	0.000675	CcSEcCtD
Raloxifene—Headache—Topiramate—obesity	7.65e-05	0.000671	CcSEcCtD
Raloxifene—Nausea—Topiramate—obesity	7.26e-05	0.000636	CcSEcCtD
Raloxifene—AOX1—Disease—IL6—obesity	4.09e-06	3.91e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—POMC—obesity	4.08e-06	3.89e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ESR1—obesity	4.07e-06	3.89e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—INS—obesity	4.06e-06	3.87e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—COMT—obesity	4.05e-06	3.87e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—F2—obesity	4.02e-06	3.84e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PRKCB—obesity	4.02e-06	3.84e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—POMC—obesity	4.02e-06	3.83e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—UCP2—obesity	4.01e-06	3.83e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HSD11B1—obesity	4.01e-06	3.83e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—UCP3—obesity	4.01e-06	3.83e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ECHS1—obesity	4.01e-06	3.83e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.01e-06	3.83e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARGC1A—obesity	4e-06	3.81e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GNB3—obesity	4e-06	3.81e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—INS—obesity	3.99e-06	3.81e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HMOX1—obesity	3.98e-06	3.8e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—BAD—obesity	3.98e-06	3.8e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.97e-06	3.79e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ADH1B—obesity	3.95e-06	3.77e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCL2—obesity	3.93e-06	3.75e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GCG—obesity	3.93e-06	3.75e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SLC2A4—obesity	3.93e-06	3.75e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PRKCD—obesity	3.91e-06	3.73e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GNAS—obesity	3.89e-06	3.71e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPAM—obesity	3.88e-06	3.71e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARGC1B—obesity	3.88e-06	3.71e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ACSL1—obesity	3.88e-06	3.71e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYCS—obesity	3.87e-06	3.7e-05	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PIK3CA—obesity	3.87e-06	3.7e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IGF1—obesity	3.86e-06	3.69e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT2—obesity	3.86e-06	3.68e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CG—obesity	3.85e-06	3.68e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR2A—obesity	3.82e-06	3.65e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—C3—obesity	3.82e-06	3.64e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOB—obesity	3.81e-06	3.64e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IRS1—obesity	3.81e-06	3.63e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GGT1—obesity	3.8e-06	3.63e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GOT1—obesity	3.8e-06	3.63e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—AKT1—obesity	3.78e-06	3.6e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HADH—obesity	3.77e-06	3.6e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PCK1—obesity	3.77e-06	3.6e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—FADS1—obesity	3.77e-06	3.6e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CD—obesity	3.77e-06	3.6e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NCOA1—obesity	3.74e-06	3.57e-05	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—AKT1—obesity	3.73e-06	3.56e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ALB—obesity	3.72e-06	3.55e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CD—obesity	3.71e-06	3.54e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP19A1—obesity	3.69e-06	3.52e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—STK11—obesity	3.69e-06	3.52e-05	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PIK3CA—obesity	3.67e-06	3.51e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SERPINE1—obesity	3.67e-06	3.5e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ACP5—obesity	3.67e-06	3.5e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—POMC—obesity	3.67e-06	3.5e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—INS—obesity	3.65e-06	3.48e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—LPL—obesity	3.64e-06	3.47e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IRS2—obesity	3.63e-06	3.47e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AGT—obesity	3.63e-06	3.46e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCL2—obesity	3.59e-06	3.42e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—G6PD—obesity	3.57e-06	3.41e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TYK2—obesity	3.57e-06	3.41e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NOS3—obesity	3.56e-06	3.4e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3R1—obesity	3.56e-06	3.4e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LEP—obesity	3.55e-06	3.39e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOE—obesity	3.55e-06	3.39e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GPX1—obesity	3.55e-06	3.39e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RHOA—obesity	3.54e-06	3.38e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HK1—obesity	3.53e-06	3.37e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SREBF2—obesity	3.53e-06	3.37e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IGF1—obesity	3.53e-06	3.37e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT2—obesity	3.52e-06	3.36e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CAV1—obesity	3.52e-06	3.36e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOA1—obesity	3.51e-06	3.35e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3R1—obesity	3.5e-06	3.34e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOS3—obesity	3.5e-06	3.34e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CD36—obesity	3.46e-06	3.3e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—COMT—obesity	3.43e-06	3.27e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LPA—obesity	3.41e-06	3.26e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CD—obesity	3.39e-06	3.23e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARGC1A—obesity	3.38e-06	3.23e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GNB3—obesity	3.38e-06	3.23e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HMOX1—obesity	3.37e-06	3.21e-05	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PIK3CA—obesity	3.35e-06	3.2e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—F2—obesity	3.35e-06	3.2e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PRKCB—obesity	3.35e-06	3.2e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SERPINE1—obesity	3.35e-06	3.2e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LPIN1—obesity	3.34e-06	3.19e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PIK3CA—obesity	3.34e-06	3.18e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—BAD—obesity	3.31e-06	3.16e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GNAS—obesity	3.29e-06	3.14e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CB—obesity	3.28e-06	3.13e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MTHFR—obesity	3.28e-06	3.13e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOA5—obesity	3.27e-06	3.12e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TYK2—obesity	3.26e-06	3.11e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—obesity	3.25e-06	3.11e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CB—obesity	3.23e-06	3.09e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MTOR—obesity	3.23e-06	3.09e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RHOA—obesity	3.23e-06	3.08e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOB—obesity	3.23e-06	3.08e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARA—obesity	3.21e-06	3.07e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CG—obesity	3.21e-06	3.06e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3R1—obesity	3.2e-06	3.05e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOS3—obesity	3.2e-06	3.05e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IRS1—obesity	3.17e-06	3.03e-05	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—AKT1—obesity	3.16e-06	3.02e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CLOCK—obesity	3.12e-06	2.98e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC22A1—obesity	3.12e-06	2.98e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AGT—obesity	3.11e-06	2.97e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—LPL—obesity	3.08e-06	2.94e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—POMC—obesity	3.05e-06	2.91e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOE—obesity	3.05e-06	2.91e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PIK3CA—obesity	3.05e-06	2.91e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SULT2A1—obesity	3.04e-06	2.9e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GLP1R—obesity	3.04e-06	2.9e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—INS—obesity	3.04e-06	2.9e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CAV1—obesity	3.02e-06	2.88e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOA1—obesity	3.01e-06	2.88e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GPX1—obesity	3.01e-06	2.87e-05	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—AKT1—obesity	3e-06	2.86e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—DPYD—obesity	2.99e-06	2.85e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCL2—obesity	2.99e-06	2.85e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—obesity	2.95e-06	2.82e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CB—obesity	2.95e-06	2.82e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MTOR—obesity	2.95e-06	2.82e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF1—obesity	2.94e-06	2.8e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT2—obesity	2.94e-06	2.8e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CD36—obesity	2.93e-06	2.79e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PRKAR2B—obesity	2.88e-06	2.75e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—DCN—obesity	2.86e-06	2.73e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CD—obesity	2.82e-06	2.69e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP9—obesity	2.81e-06	2.68e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SERPINE1—obesity	2.79e-06	2.66e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CPT1A—obesity	2.78e-06	2.65e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MTHFR—obesity	2.77e-06	2.65e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CG—obesity	2.75e-06	2.63e-05	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—AKT1—obesity	2.74e-06	2.61e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAPK8—obesity	2.73e-06	2.61e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NAMPT—obesity	2.73e-06	2.6e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—AKT1—obesity	2.73e-06	2.6e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARA—obesity	2.72e-06	2.6e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MYC—obesity	2.72e-06	2.59e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TYK2—obesity	2.71e-06	2.59e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LIPC—obesity	2.71e-06	2.59e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCK—obesity	2.71e-06	2.59e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—obesity	2.7e-06	2.57e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOC3—obesity	2.69e-06	2.57e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RHOA—obesity	2.69e-06	2.57e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3R1—obesity	2.66e-06	2.54e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOS3—obesity	2.66e-06	2.54e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARG—obesity	2.66e-06	2.54e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AGT—obesity	2.64e-06	2.52e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—POMC—obesity	2.62e-06	2.5e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CETP—obesity	2.61e-06	2.49e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—INS—obesity	2.61e-06	2.49e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SDC1—obesity	2.58e-06	2.47e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOE—obesity	2.58e-06	2.46e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP9—obesity	2.57e-06	2.45e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CAV1—obesity	2.56e-06	2.44e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOA1—obesity	2.55e-06	2.44e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKR1C3—obesity	2.54e-06	2.43e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SCARB1—obesity	2.5e-06	2.39e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—STAT3—obesity	2.5e-06	2.38e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAPK8—obesity	2.49e-06	2.38e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—AKT1—obesity	2.49e-06	2.37e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CB—obesity	2.46e-06	2.35e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MTOR—obesity	2.46e-06	2.35e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.44e-06	2.33e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SREBF1—obesity	2.43e-06	2.32e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CD—obesity	2.42e-06	2.31e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ALB—obesity	2.39e-06	2.28e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GOT2—obesity	2.36e-06	2.26e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CG—obesity	2.33e-06	2.22e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MYC—obesity	2.32e-06	2.22e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TGFB1—obesity	2.32e-06	2.21e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—FASN—obesity	2.31e-06	2.21e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—BCHE—obesity	2.3e-06	2.2e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NOS3—obesity	2.28e-06	2.18e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3R1—obesity	2.28e-06	2.18e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—STAT3—obesity	2.28e-06	2.18e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARG—obesity	2.25e-06	2.15e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2E1—obesity	2.22e-06	2.12e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—POMC—obesity	2.22e-06	2.12e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—INS—obesity	2.21e-06	2.11e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NQO1—obesity	2.2e-06	2.1e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP9—obesity	2.14e-06	2.04e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MYC—obesity	2.12e-06	2.02e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TGFB1—obesity	2.11e-06	2.02e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CB—obesity	2.11e-06	2.01e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCG—obesity	2.11e-06	2.01e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC2A4—obesity	2.11e-06	2.01e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—obesity	2.09e-06	1.99e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYCS—obesity	2.08e-06	1.98e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAPK8—obesity	2.08e-06	1.98e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CD—obesity	2.05e-06	1.96e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GGT1—obesity	2.04e-06	1.95e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GOT1—obesity	2.04e-06	1.95e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALB—obesity	2.02e-06	1.93e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NCOA1—obesity	2.01e-06	1.92e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CA—obesity	2e-06	1.91e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—STK11—obesity	1.98e-06	1.89e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP19A1—obesity	1.98e-06	1.89e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CA—obesity	1.97e-06	1.88e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NOS3—obesity	1.93e-06	1.85e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3R1—obesity	1.93e-06	1.85e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—STAT3—obesity	1.9e-06	1.81e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—AKT1—obesity	1.88e-06	1.8e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—COMT—obesity	1.84e-06	1.76e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARGC1A—obesity	1.82e-06	1.73e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GNB3—obesity	1.82e-06	1.73e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HMOX1—obesity	1.81e-06	1.73e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CA—obesity	1.8e-06	1.72e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CB—obesity	1.79e-06	1.7e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—obesity	1.77e-06	1.69e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GNAS—obesity	1.77e-06	1.69e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MYC—obesity	1.77e-06	1.69e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFB1—obesity	1.76e-06	1.68e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—obesity	1.75e-06	1.67e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOB—obesity	1.73e-06	1.65e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LPL—obesity	1.65e-06	1.58e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AKT1—obesity	1.64e-06	1.56e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPX1—obesity	1.61e-06	1.54e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT1—obesity	1.61e-06	1.54e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—obesity	1.59e-06	1.52e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CD36—obesity	1.57e-06	1.5e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CA—obesity	1.5e-06	1.43e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTHFR—obesity	1.49e-06	1.42e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT1—obesity	1.47e-06	1.4e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARA—obesity	1.46e-06	1.39e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AGT—obesity	1.41e-06	1.35e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOE—obesity	1.39e-06	1.32e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CAV1—obesity	1.37e-06	1.31e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOA1—obesity	1.37e-06	1.31e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—obesity	1.33e-06	1.27e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CA—obesity	1.29e-06	1.23e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CG—obesity	1.25e-06	1.19e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT1—obesity	1.22e-06	1.17e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARG—obesity	1.21e-06	1.15e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—POMC—obesity	1.19e-06	1.14e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—INS—obesity	1.18e-06	1.13e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CD—obesity	1.1e-06	1.05e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CA—obesity	1.09e-06	1.04e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALB—obesity	1.09e-06	1.04e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKT1—obesity	1.05e-06	1e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3R1—obesity	1.04e-06	9.91e-06	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NOS3—obesity	1.04e-06	9.91e-06	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CB—obesity	9.58e-07	9.15e-06	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—obesity	9.5e-07	9.06e-06	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKT1—obesity	8.89e-07	8.49e-06	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CA—obesity	5.84e-07	5.58e-06	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKT1—obesity	4.77e-07	4.56e-06	CbGpPWpGaD
